These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3222486)

  • 1. Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene.
    Bogen KT
    Regul Toxicol Pharmacol; 1988 Dec; 8(4):447-66. PubMed ID: 3222486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
    Fisher JW
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):265-73. PubMed ID: 10807557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
    Evans MV; Chiu WA; Okino MS; Caldwell JC
    Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.
    Allen BC; Fisher JW
    Risk Anal; 1993 Feb; 13(1):71-86. PubMed ID: 8451462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
    Clewell HJ; Andersen ME
    Crit Rev Toxicol; 2004; 34(5):385-445. PubMed ID: 15560567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
    Abbas R; Fisher JW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.
    Dobrev ID; Andersen ME; Yang RS
    Arch Toxicol; 2001 May; 75(3):134-44. PubMed ID: 11409535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in the pharmacokinetics of trichloroethylene and its metabolites.
    Chiu WA; Okino MS; Lipscomb JC; Evans MV
    Environ Health Perspect; 2006 Sep; 114(9):1450-6. PubMed ID: 16966104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW; Mahle D; Abbas R
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichloroethylene risk assessment: a review and commentary.
    Jollow DJ; Bruckner JV; McMillan DC; Fisher JW; Hoel DG; Mohr LC
    Crit Rev Toxicol; 2009; 39(9):782-97. PubMed ID: 19852561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
    Keys DA; Bruckner JV; Muralidhara S; Fisher JW
    Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.
    Cronin WJ; Oswald EJ; Shelley ML; Fisher JW; Flemming CD
    Risk Anal; 1995 Oct; 15(5):555-65. PubMed ID: 7501875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics.
    Yoon M; Madden MC; Barton HA
    J Toxicol Environ Health A; 2007 Sep; 70(18):1527-41. PubMed ID: 17710613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Momentary brain concentration of trichloroethylene predicts the effects on rat visual function.
    Boyes WK; Bercegeay M; Krantz T; Evans M; Benignus V; Simmons JE
    Toxicol Sci; 2005 Sep; 87(1):187-96. PubMed ID: 15976185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
    Clewell HJ; Gentry PR; Covington TR; Gearhart JM
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):283-305. PubMed ID: 10807559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
    Fisher JW; Allen BC
    Risk Anal; 1993 Feb; 13(1):87-95. PubMed ID: 8451463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS; Burton GA; Fisher JW
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling.
    Poet TS; Corley RA; Thrall KD; Edwards JA; Tanojo H; Weitz KK; Hui X; Maibach HI; Wester RC
    Toxicol Sci; 2000 Jul; 56(1):61-72. PubMed ID: 10869454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.